Cervical cancer prevention in the United States—where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative

Ritu Nayar

doi:10.1002/cncy.22733

Cervical cancer prevention in the United States—where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative

Ritu Nayar^*

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Comment/debate › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	747-750
Number of pages	4
Journal	Cancer Cytopathology
Volume	131
Issue number	12
DOIs	https://doi.org/10.1002/cncy.22733
State	Published - Dec 2023

Funding

Steering Committee and Laboratory Infrastructure Workgroup members of the American Cancer Society's Primary HPV Screening Initiative provided input to support the development of this commentary. Special thanks to Levi S. Downs Jr, MD; Eduardo L. Franco, MPH, DrPH, PhD(Hon); Francisco García, MD. MPH; Akiva P. Novetsky, MD, MS; Rebecca B, Perkins, MD; Robert A. Smith, PhD; Debbie Saslow, PhD; and Jane Gerndt, MPH, for their review of this article.

Keywords

ASCCP management guidelines
Enduring guidelines
HPV vaccine
cervical cancer
cotesting
cytology
elimination
human papillomavirus (HPV)
implementation
prevention
primary HPV screening

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cncy.22733

Cite this

@article{156cb9e76b5941bbbd270170f193cddc,

title = "Cervical cancer prevention in the United States—where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative",

keywords = "ASCCP management guidelines, Enduring guidelines, HPV vaccine, cervical cancer, cotesting, cytology, elimination, human papillomavirus (HPV), implementation, prevention, primary HPV screening",

author = "Ritu Nayar",

year = "2023",

month = dec,

doi = "10.1002/cncy.22733",

language = "English (US)",

volume = "131",

pages = "747--750",

journal = "Cancer Cytopathology",

issn = "1934-662X",

publisher = "John Wiley and Sons Inc.",

number = "12",

}

TY - JOUR

T1 - Cervical cancer prevention in the United States—where we've been and where we're going

T2 - The American Cancer Society Primary HPV Screening Initiative

AU - Nayar, Ritu

PY - 2023/12

Y1 - 2023/12

KW - ASCCP management guidelines

KW - Enduring guidelines

KW - HPV vaccine

KW - cervical cancer

KW - cotesting

KW - cytology

KW - elimination

KW - human papillomavirus (HPV)

KW - implementation

KW - prevention

KW - primary HPV screening

UR - https://www.scopus.com/pages/publications/85162675479

UR - https://www.scopus.com/inward/citedby.url?scp=85162675479&partnerID=8YFLogxK

U2 - 10.1002/cncy.22733

DO - 10.1002/cncy.22733

M3 - Comment/debate

C2 - 37347982

AN - SCOPUS:85162675479

SN - 1934-662X

VL - 131

SP - 747

EP - 750

JO - Cancer Cytopathology

JF - Cancer Cytopathology

IS - 12

ER -

Cervical cancer prevention in the United States—where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this